NASDAQ:PDCO - Patterson Companies Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $25.33
  • Forecasted Upside: -26.68 %
  • Number of Analysts: 8
  • Breakdown:
  • 1 Sell Ratings
  • 4 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$34.55
▼ -0.72 (-2.04%)
1 month | 3 months | 12 months
Get New Patterson Companies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PDCO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PDCO

Average Price Target: $25.33
▼ -26.68% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for Patterson Companies in the last 3 months. The average price target is $25.33, with a high forecast of $33.00 and a low forecast of $21.00. The average price target represents a -26.68% upside from the last price of $34.55.

Hold

The current consensus among 8 polled investment analysts is to hold stock in Patterson Companies. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 8 hold ratings
  • 1 sell ratings
12/29/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 8 hold ratings
  • 1 sell ratings
3/28/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 8 hold ratings
  • 1 sell ratings
6/26/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 1 sell ratings
9/24/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 6 hold ratings
  • 1 sell ratings
12/23/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 1 sell ratings
3/23/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 1 sell ratings
5/22/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 1 sell ratings
6/21/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/17/2021Piper SandlerUpgradeNeutral ➝ OverweightHigh
12/3/2020BarclaysBoost Price TargetUnderweight$21.00 ➝ $25.00Medium
12/2/2020Piper SandlerBoost Price TargetNeutral$25.00 ➝ $33.00High
11/10/2020GuggenheimDowngradeBuy ➝ NeutralLow
9/4/2020BarclaysBoost Price TargetUnderweight$18.00 ➝ $21.00Medium
8/27/2020Bank of AmericaBoost Price TargetBuy$27.50 ➝ $31.00Low
7/20/2020Bank of AmericaBoost Price TargetBuy$23.00 ➝ $27.50High
6/29/2020Credit Suisse GroupReiterated RatingBuyLow
6/26/2020UBS GroupBoost Price TargetNeutral$20.00 ➝ $21.00High
6/25/2020JPMorgan Chase & Co.Boost Price TargetNeutral$19.00 ➝ $21.00High
6/25/2020The Goldman Sachs GroupUpgradeSell ➝ Neutral$11.00 ➝ $21.00High
4/2/2020Wolfe ResearchUpgradeUnderperform ➝ Market PerformMedium
3/20/2020BarclaysReiterated RatingSell$16.00Medium
2/28/2020Robert W. BairdBoost Price TargetNeutral$22.00 ➝ $28.00Low
2/28/2020JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$20.00 ➝ $25.00High
2/28/2020BarclaysReiterated RatingSell$21.00High
2/27/2020Bank of AmericaUpgradeNeutral ➝ Buy$28.00High
1/9/2020Bank of AmericaUpgradeUnderperform ➝ Neutral$19.50 ➝ $22.50Medium
1/7/2020GuggenheimUpgradeNeutral ➝ Buy$25.00High
12/18/2019CfraUpgradeStrong Sell ➝ HoldLow
12/6/2019JPMorgan Chase & Co.Boost Price TargetUnderweight$18.00 ➝ $20.00Medium
12/6/2019Robert W. BairdBoost Price TargetNeutral$19.00 ➝ $22.00Low
12/4/2019William BlairReiterated RatingMarket PerformHigh
9/6/2019UBS GroupLower Price TargetNeutral$23.00 ➝ $16.00Low
8/30/2019The Goldman Sachs GroupSet Price TargetSell$15.00Low
8/30/2019Robert W. BairdSet Price TargetHold$19.00Low
8/30/2019Wolfe ResearchSet Price TargetSell$17.00Low
8/30/2019BarclaysLower Price TargetUnderweight$20.00 ➝ $16.00Low
6/28/2019JPMorgan Chase & Co.Lower Price TargetUnderweight$22.00 ➝ $20.00High
6/25/2019UBS GroupSet Price TargetHold$24.00High
5/30/2019Wolfe ResearchInitiated CoverageUnderperform ➝ UnderperformLow
4/17/2019GuggenheimInitiated CoverageNeutral ➝ Neutral$23.00Medium
1/17/2019UBS GroupInitiated CoverageNeutral ➝ Neutral$23.00Low
10/19/2018The Goldman Sachs GroupInitiated CoverageSell ➝ Sell$19.00Medium
8/31/2018Morgan StanleyLower Price TargetUnderweight ➝ Underweight$21.00 ➝ $19.00Medium
8/31/2018BarclaysLower Price TargetUnderweight ➝ Underweight$23.00 ➝ $20.00Low
8/10/2018SVB LeerinkInitiated CoverageMarket Perform$25.00High
6/22/2018Morgan StanleyBoost Price TargetUnderweight ➝ Underweight$20.00 ➝ $21.00Medium
6/21/2018Evercore ISILower Price TargetUnderperform$20.00 ➝ $18.50High
6/18/2018Stifel NicolausLower Price TargetHold ➝ Hold$28.00 ➝ $23.00High
6/7/2018JPMorgan Chase & Co.Lower Price TargetUnderweight ➝ Underweight$26.00 ➝ $24.00Low
5/29/2018Bank of AmericaLower Price TargetUnderperform ➝ Underperform$22.00 ➝ $20.00Low
5/16/2018Northcoast ResearchReiterated RatingBuyMedium
4/6/2018Craig HallumUpgradeHold ➝ BuyMedium
4/4/2018Piper Jaffray CompaniesReiterated RatingHold$24.00High
3/8/2018BarclaysInitiated CoverageUnderweight ➝ Underweight$23.00Low
3/6/2018Jefferies Financial GroupReiterated RatingHold$26.00Low
3/5/2018JPMorgan Chase & Co.Lower Price TargetUnderweight ➝ Underweight$36.00 ➝ $26.00Low
3/1/2018Northcoast ResearchSet Price TargetBuy$38.00High
3/1/2018Evercore ISIDowngradeIn-Line ➝ UnderperformHigh
3/1/2018Robert W. BairdDowngradeOutperform ➝ NeutralHigh
2/15/2018JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$40.00 ➝ $36.00Low
1/4/2018Evercore ISIInitiated CoverageIn ➝ In-Line$38.50Low
12/8/2017Deutsche Bank AktiengesellschaftInitiated CoverageHold ➝ Hold$37.00Low
12/6/2017Morgan StanleyDowngradeEqual Weight ➝ Underweight$42.00Low
11/23/2017Jefferies Financial GroupReiterated RatingHold$37.00N/A
11/22/2017Robert W. BairdReiterated RatingBuy$40.00N/A
11/15/2017Stifel NicolausUpgradeSell ➝ Hold$34.00N/A
11/10/2017Robert W. BairdReiterated RatingBuy$44.00N/A
10/19/2017Piper Jaffray CompaniesInitiated CoverageNeutral ➝ Neutral$41.00N/A
9/26/2017Robert W. BairdReiterated RatingBuy$44.00Low
9/21/2017Morgan StanleyInitiated CoverageEqual ➝ Equal Weight$42.00Medium
9/19/2017Royal Bank of CanadaInitiated CoverageSector Perform ➝ Sector Perform$42.00Medium
8/25/2017UBS GroupUpgradeSell ➝ Hold$40.00Medium
8/22/2017Cleveland ResearchReiterated RatingHoldHigh
8/17/2017Craig HallumReiterated RatingHold ➝ Sell$46.00 ➝ $41.00Low
8/15/2017Stifel NicolausLower Price TargetSell ➝ Sell$39.00 ➝ $34.00High
7/13/2017Credit Suisse GroupReiterated RatingOutperform$45.00 ➝ $50.00Low
7/11/2017UBS GroupDowngradeNeutral ➝ Sell$44.50 ➝ $40.00Medium
7/6/2017Stifel NicolausDowngradeHold ➝ Sell$47.43 ➝ $39.00High
5/15/2017Jefferies Financial GroupReiterated RatingHold$40.00Low
5/5/2017Jefferies Financial GroupReiterated RatingHold$40.00Low
4/11/2017Craig HallumInitiated CoverageHoldLow
3/29/2017Jefferies Financial GroupReiterated RatingHold$40.00Low
3/15/2017Deutsche Bank AktiengesellschaftInitiated CoverageHold ➝ Hold$45.00Medium
3/3/2017Evercore ISIDowngradeHold ➝ UnderperformN/A
3/1/2017Credit Suisse GroupReiterated RatingHold$45.00N/A
1/30/2017Stifel NicolausReiterated RatingHold$39.00N/A
1/3/2017Robert W. BairdUpgradeNeutral ➝ Outperform$38.00 ➝ $47.00N/A
11/29/2016Jefferies Financial GroupLower Price TargetHold$50.00 ➝ $40.00N/A
11/28/2016Evercore ISIReiterated RatingHold$46.00 ➝ $39.00N/A
11/25/2016Jefferies Financial GroupReiterated RatingNeutral$48.00N/A
11/23/2016Off Wall StreetReiterated RatingSellN/A
11/22/2016Robert W. BairdSet Price TargetHold$48.00N/A
11/22/2016Evercore ISILower Price Target$39.00N/A
11/1/2016Northcoast ResearchReiterated RatingBuyN/A
10/5/2016UBS GroupInitiated CoverageNeutral$48.00N/A
8/26/2016Evercore ISIReiterated RatingHold$49.00 ➝ $48.00N/A
8/26/2016Robert W. BairdReiterated RatingNeutral$51.00 ➝ $49.00N/A
8/24/2016Bank of AmericaInitiated CoverageUnderperform$44.00N/A
8/8/2016Off Wall StreetInitiated CoverageSellN/A
8/4/2016Jefferies Financial GroupReiterated RatingHoldN/A
6/27/2016Credit Suisse GroupReiterated RatingBuy$55.00N/A
(Data available from 6/21/2016 forward)
Patterson Companies logo
Patterson Companies, Inc. distributes and sells dental and animal health products in the United States, the United Kingdom, and Canada. It operates through three segments; Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, hand instruments, and sterilization products; basic and advanced technology dental equipment; technology solutions, such as practice management software and e-commerce solutions; patient education systems; and office forms and stationery. It also provides a range of related services comprising software and design services, maintenance and repair, and equipment financing. The Animal Health segment distributes pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritionals, consumable supplies, equipment, and software, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. The Corporate segment offers customer financing services; and sells other miscellaneous products. It serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in Saint Paul, Minnesota.
Read More

Today's Range

Now: $34.55
Low: $34.21
High: $35.02

50 Day Range

MA: $34.13
Low: $31.96
High: $36.63

52 Week Range

Now: $34.55
Low: $18.87
High: $37.37

Volume

1,011,400 shs

Average Volume

782,841 shs

Market Capitalization

$3.34 billion

P/E Ratio

N/A

Dividend Yield

3.01%

Beta

1.6

Frequently Asked Questions

What sell-side analysts currently cover shares of Patterson Companies?

The following Wall Street sell-side analysts have issued stock ratings on Patterson Companies in the last twelve months: Bank of America Co., Barclays PLC, Credit Suisse Group AG, Guggenheim, JPMorgan Chase & Co., Piper Sandler, The Goldman Sachs Group, Inc., TheStreet, UBS Group AG, and Zacks Investment Research.
View the latest analyst ratings for PDCO.

What is the current price target for Patterson Companies?

6 Wall Street analysts have set twelve-month price targets for Patterson Companies in the last year. Their average twelve-month price target is $25.33, suggesting a possible downside of 26.7%. Piper Sandler has the highest price target set, predicting PDCO will reach $33.00 in the next twelve months. UBS Group AG has the lowest price target set, forecasting a price of $21.00 for Patterson Companies in the next year.
View the latest price targets for PDCO.

What is the current consensus analyst rating for Patterson Companies?

Patterson Companies currently has 1 sell rating, 4 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in PDCO, but not buy more shares or sell existing shares.
View the latest ratings for PDCO.

What other companies compete with Patterson Companies?

Other companies that are similar to Patterson Companies include McKesson, AmerisourceBergen, Cardinal Health, Henry Schein and Owens & Minor.

How do I contact Patterson Companies' investor relations team?

Patterson Companies' physical mailing address is 1031 MENDOTA HEIGHTS RD, ST PAUL MN, 55120. The company's listed phone number is 651-686-1600 and its investor relations email address is [email protected] The official website for Patterson Companies is www.pattersoncompanies.com.